Search research articles
Contact Us
Filters
Showing results (1-10 of 16) with videos related to
Page
of 2
Sort By:
Therapeutic Advances in Psychopharmacology
|
November 4, 2021
MTORC1 signaling as a biomarker in major depressive disorder and its pharmacological modulation by novel rapid-acting antidepressants
Tomasz Cholewinski, Diana Pereira, Matthijs Moerland, et al.
The Lancet. Psychiatry
|
August 29, 2016
Question-based Drug Development for psilocybin
Francis M Dijkstra, Gabriel E Jacobs, Adam F Cohen
Annals of Intensive Care
|
September 4, 2016
Unsuspected serotonin toxicity in the ICU
Catharina E van Ewijk, Gabriel E Jacobs, Armand R J Girbes
Nederlands Tijdschrift Voor Geneeskunde
|
September 14, 2018
[Valproic acid toxicity due to misinterpretation of plasma levels: increase in unbound fraction caused by hypoalbuminaemia and renal dysfunction]
Roos Ruiter-Visser, Annemieke Dols, Yvo M Smulders, et al.
Digital Biomarkers
|
February 26, 2020
A Pilot Study Evaluating the Physiological Parameters of Performance-Induced Stress in Undergraduate Music Students
Esther M van Fenema, Pim Gal, Maxime V van de Griend, et al.
Psychotherapy and Psychosomatics
|
July 25, 2018
Failure to Respond after Reinstatement of Antidepressant Medication: A Systematic Review
Renske C Bosman, Ruth C Waumans, Gabriel E Jacobs, et al.
Clinical Pharmacokinetics
|
January 15, 2025
Clinical Pharmacokinetics of Psilocin After Psilocybin Administration: A Systematic Review and Post-Hoc Analysis
Marije E Otto, Katelijne V van der Heijden, Jan W Schoones, et al.
Clinical Pharmacokinetics
|
February 21, 2025
Correction: Clinical Pharmacokinetics of Psilocin After Psilocybin Administration: A Systematic Review and Post‑Hoc Analysis
Marije E Otto, Katelijne V van der Heijden, Jan W Schoones, et al.
Translational Psychiatry
|
July 23, 2023
Characterization of the central nervous system penetrant and selective purine P2X7 receptor antagonist JNJ-54175446 in patients with major depressive disorder
Kasper Recourt, Peter de Boer, Peter van der Ark, et al.
Cells
|
October 28, 2025
Biomarker-Based Pharmacological Characterization of ENX-102, a Novel α2/3/5 Subtype-Selective GABAA Receptor Positive Allo-Steric Modulator: Translational Insights from Rodent and Human Studies
Pauline Nettesheim, Krishna C Vadodaria, Kimberly E Vanover, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 16) with videos related to
Sort By:
Page
of 2
Therapeutic Advances in Psychopharmacology
|
November 4, 2021
MTORC1 signaling as a biomarker in major depressive disorder and its pharmacological modulation by novel rapid-acting antidepressants
Tomasz Cholewinski, Diana Pereira, Matthijs Moerland, et al.
The Lancet. Psychiatry
|
August 29, 2016
Question-based Drug Development for psilocybin
Francis M Dijkstra, Gabriel E Jacobs, Adam F Cohen
Annals of Intensive Care
|
September 4, 2016
Unsuspected serotonin toxicity in the ICU
Catharina E van Ewijk, Gabriel E Jacobs, Armand R J Girbes
Nederlands Tijdschrift Voor Geneeskunde
|
September 14, 2018
[Valproic acid toxicity due to misinterpretation of plasma levels: increase in unbound fraction caused by hypoalbuminaemia and renal dysfunction]
Roos Ruiter-Visser, Annemieke Dols, Yvo M Smulders, et al.
Digital Biomarkers
|
February 26, 2020
A Pilot Study Evaluating the Physiological Parameters of Performance-Induced Stress in Undergraduate Music Students
Esther M van Fenema, Pim Gal, Maxime V van de Griend, et al.
Psychotherapy and Psychosomatics
|
July 25, 2018
Failure to Respond after Reinstatement of Antidepressant Medication: A Systematic Review
Renske C Bosman, Ruth C Waumans, Gabriel E Jacobs, et al.
Clinical Pharmacokinetics
|
January 15, 2025
Clinical Pharmacokinetics of Psilocin After Psilocybin Administration: A Systematic Review and Post-Hoc Analysis
Marije E Otto, Katelijne V van der Heijden, Jan W Schoones, et al.
Clinical Pharmacokinetics
|
February 21, 2025
Correction: Clinical Pharmacokinetics of Psilocin After Psilocybin Administration: A Systematic Review and Post‑Hoc Analysis
Marije E Otto, Katelijne V van der Heijden, Jan W Schoones, et al.
Translational Psychiatry
|
July 23, 2023
Characterization of the central nervous system penetrant and selective purine P2X7 receptor antagonist JNJ-54175446 in patients with major depressive disorder
Kasper Recourt, Peter de Boer, Peter van der Ark, et al.
Cells
|
October 28, 2025
Biomarker-Based Pharmacological Characterization of ENX-102, a Novel α2/3/5 Subtype-Selective GABAA Receptor Positive Allo-Steric Modulator: Translational Insights from Rodent and Human Studies
Pauline Nettesheim, Krishna C Vadodaria, Kimberly E Vanover, et al.
Page
of 2